02041nas a2200373   4500000000100000008004100001260001300042653001500055653001000070653000900080653002100089653001100110653002100121653003400142653001100176653001400187653002200201653001200223653000900235653001600244653003700260653002300297653002600320653002100346653001900367100001500386245012700401856006000528300001100588490000700599050003200606520101500638022001401653       1998                            d  c1998 Sep10aAdolescent10aAdult10aChad10aDisabled Persons10aFemale10aHealth Education10aHealth Services Accessibility10aHumans10aIncidence10aInfection Control10aleprosy10aMale10aMiddle Aged10aOutcome Assessment (Health Care)10aProgram evaluation10aRetrospective Studies10aSex Distribution10aWomen's Health1 aSchäfer J00aLeprosy and disability control in the Guéra prefecture of Chad, Africa: do women have access to leprosy control services?  uhttp://leprev.ilsl.br/sumario.php?ano=1998&volume=v69n3  a267-780 v69  aInfolep Library - available3 a<p>In a retrospective study, data from the Guéra Leprosy and Disability Control Project in Chad, covering the years from 1992 to 1996, were analysed in order to determine whether there was any indication that the quality of care provided to female leprosy sufferers is inferior to the care provided for male patients. Data from a total of 741 patient registered for MDT, of whom 351 were newly diagnosed cases, are presented and discussed. The data indicate that women have access to diagnosis and treatment and health education. They do not present for treatment later than men, disability rates are lower and they have slightly higher treatment completion rates. Both women and men benefit from footwear and loan programs. More women than men are involved in patient self-help groups. The study shows that in this part of central Chad, there is no evidence of disadvantage for women with leprosy in either diagnosis, treatment or follow-up, but more qualitative data is needed to confirm these findings.</p>  a0305-7518